Basal cell carcinoma: a paradigm for targeted therapies

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.14, Iss.10, 2013-07, pp. : 1307-1318

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New targeted therapies for renal cell carcinoma

By Fisher Rosalie Pickering Lisa Larkin James

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 7, 2011-07 ,pp. : 933-945

Informa Healthcare

Access to resources Recommend Favorite

New Treatments for Renal Cell Carcinoma: Targeted Therapies

By Saylor Philip J. Michaelson M. Dror

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 7, Iss. 6, 2009-06 ,pp. : 645-656

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Emerging Targeted Therapies in Metastatic Renal Cell Carcinoma

Current Clinical Pharmacology, Vol. 6, Iss. 3, 2011-08 ,pp. : 189-198

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Therapies in the Treatment of Renal Cell Carcinoma

Current Medicinal Chemistry, Vol. 15, Iss. 12, 2008-05 ,pp. : 1166-1174

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Therapies in Hepatocellular Carcinoma

Current Medicinal Chemistry, Vol. 21, Iss. 8, 2014-03 ,pp. : 966-974

Bentham Science Publishers

Access to resources Recommend Favorite